NeurAxis's robust sales growth and disciplined cost management have set the stage for achieving cash flow breakeven in 2026. Notably, recent investments from life science-focused funds have bolstered ...
ANI is offering prucalopride tablets, which is the generic of Takeda's Motegrity. Motegrity is used in adults to treat chronic idiopathic constipation. "We are delighted to build momentum early in ...